Journal of Cell Biology 'Under Review': What Each Status Means
If your JCB submission shows Under Review, here is what the in-house professional editors and academic editorial board are doing during each stage and when to follow up.
While you wait
Waiting on Journal of Cell Biology? Get your next move ready.
The Journal of Cell Biology wait is out of your hands; the next move isn't. Scan your next manuscript free, or run this paper through the scan to see what reviewers typically push back on, so the revision response is ready when the decision lands.
Journal of Cell Biology review timeline: what the data shows
Time to first decision is the most actionable number. What happens after varies by manuscript and reviewer availability.
What shapes the timeline
- Use the publisher's current timing summary; do not assume a fixed desk-decision deadline.
- Editorial assignment, reviewer availability, topic, and revisions can all affect elapsed time.
- Revision and additional experiments can extend the timeline; the decision letter supplies the actual revision deadline.
What to do while waiting
- Track the record in the submission portal; a status label alone does not prove external review has begun.
- Follow the journal's status-inquiry guidance and any deadline in its correspondence.
- Prepare revision materials in parallel if you expect a revise-and-resubmit decision.
Last reviewed: 2026-10-09. Quick answer: If your JCB submission shows "Under Review," elapsed time is the most reliable signal. Journal of Cell Biology has a 2025 Journal Impact Factor of 6.1 in the 2026 JCR release, and is commonly estimated to accept roughly 15 to 20 percent of submissions, and Rockefeller University Press reports that an initial decision whether to peer review the paper is typically reached within 3 to 4 days (per the JCB About page).
At JCB, all editorial decisions on research manuscripts are made through collaborative consultation between in-house professional scientific editors and the academic editorial board. The final decision lies with the academic editors. JCB's policy is to only allow a single round of major revision.
Use this guide to interpret the Journal of Cell Biology under review status, decide whether the wait is normal, and prepare the image-data or single-revision evidence reviewers are likely to ask for.
For a second opinion before reviewers see your manuscript, run a JCB submission readiness check.
What submission portal does Journal of Cell Biology use?
JCB uses the Rockefeller University Press online manuscript submission system at jcb.msubmit.net. Editorial questions should reference the manuscript ID; the journal office can be reached at cellbio@rockefeller.edu. The JCB submission guidelines cover the editorial workflow and the JCB editorial policies page covers journal policies.
For cross-publisher status-tracking baseline, the Cell Press author status portal gives useful baseline patterns for reading editorial status fields across cell-biology publishers. The Nature Cell Biology editorial process page at Nature Portfolio journal page is another cell-biology reference baseline.
How Rockefeller University Press handles a JCB submission
JCB operates the in-house professional handling editor + academic editorial board collaborative model. At JCB, all editorial decisions on research manuscripts are made through collaborative consultation between in-house professional scientific editors and the academic editorial board. The in-house professional scientific editors work with the academic editorial board, which is made up of over 100 leading scientists from across the breadth of cell biology.
The final decision lies with the academic editors.
JCB editorial culture is decisive: a 3 to 4 day initial decision means scope and quality issues surface fast. Papers that pass the JCB collaborative editor screen have cleared the steepest filter in cell-biology specialty publishing.
JCB's review pipeline
Status | What is happening | Typical duration |
|---|---|---|
Submitted | Administrative processing at JCB editorial office | No published timing |
With In-House Editor | In-house professional scientific editor evaluating desk-screen fit | Initial decision typically within 3 to 4 days |
Academic Editor Consultation | Academic editorial board collaborative consultation | Part of the same initial decision |
Under Review | External reviewers invited or actively reviewing | No published timing |
Required Reviews Complete | Academic editor synthesizing reports | No published timing |
Decision Pending | Final decision by academic editor (in collaborative consultation with in-house) | No published timing |
Decision Sent | Reject, R&R (single round), or accept | Check email |
The in-house + academic editor desk screen (about 70 percent returned without review, per a 2024 JCB editor seminar)
Before the paper reaches external reviewers, a JCB in-house professional scientific editor and academic editorial board member evaluate whether the cell-biology significance warrants JCB's selective editorial slots. A 2024 seminar by a JCB scientific editor reported that about 70% of submissions are returned without peer review; JCB publishes no official rate, and its About page says an initial decision is typically reached within three to four days.
A desk rejection most often means the editors concluded that the work would fit better at a sister cell-biology journal (Molecular Biology of the Cell from ASCB, Journal of Cell Science from Company of Biologists, sister Rockefeller journals JEM and JGP) or that the cell-biology priority bar is not met. The collaborative in-house + academic model means desk-screen decisions reflect both professional editorial judgment and academic subspecialty expertise.
Administrative processing
A complete JCB submission includes the manuscript (a single PDF or separate files), a cover letter directed to the editor, conflict-of-interest declarations, ethics-statement documentation where applicable, and a data-availability statement. JCB's guidelines encourage reporting guidelines such as ARRIVE for animal research, and they encourage depositing other data in an appropriate public repository.
In-house professional editor desk screen (typically 3 to 4 days)
The in-house professional scientific editor reads the paper and evaluates general suitability and strength of advance. JCB says an initial decision whether to peer review the paper is typically reached within three to four days.
Academic editorial board consultation
Alongside the in-house professional editor's read, a member of the editorial board reviews each submission for general suitability and strength of advance. This collaborative consultation is central to JCB's process: all editorial decisions are made through collaborative consultation between in-house professional scientific editors and the academic editorial board, with the final decision lying with the academic editors.
External reviewer recruitment
If sent for full review, the manuscript is refereed by leading scientists active in the relevant field regardless of their membership on the JCB editorial board. JCB publishes no reviewer-count or recruitment-time figures.
Active peer review
JCB asks reviewers to comment on the level of conceptual advance and broad interest, as well as the technical rigor, statistical analysis, and presentation of the manuscript, and all reviewers can see each other's comments and modify their own before a decision is made. JCB publishes no figure for how long this stage takes.
Editorial synthesis and decision
After reports return, decisions are communicated jointly by the academic and professional editors. Following review, the journal will encourage resubmission if revisions seem feasible within 3 to 4 months. JCB's policy is to only allow a single round of major revision.
When to worry
- Rejection within 1 to 3 days: Administrative issue or immediate scope mismatch.
- Rejection within 3 to 5 days: In-house + academic editor desk rejection per the 3 to 4 day initial decision.
- Still Under Review after 1 week: Strong signal. Paper passed the collaborative editor screen.
- Still Under Review after 8 weeks: Possible reviewer-recruitment or reviewer-report delay. A polite inquiry via the JCB online submission system is appropriate.
- Status changes to "Decision Pending": Reports are in; the decision follows.
"My paper has been Under Review for 4 weeks. Is that bad?"
This is the most common anxiety we hear from JCB authors during the active editorial window. The honest answer: no. JCB publishes no median review time, so 4 weeks at Under Review is not by itself a warning sign. Reports may already be in editorial synthesis with the academic editor preparing the final decision in collaborative consultation with the in-house professional editor.
Reviewer recruitment and reviewer extensions are common reasons for a longer wait, and JCB does not publish its own breakdown of what drives it. If the portal still says Under Review at the 6-week mark, that alone does not signal a problem.
What you should NOT do during the 4-to-6-week window is email the editorial office unless something urgent arises.
What to do while waiting
- Do not email the editorial office during the first 4 weeks unless an urgent ethics issue surfaces.
- Do not submit the paper anywhere else while it is Under Review at JCB. JCB has explicit prohibitions on dual submission.
- Prepare a point-by-point response template for likely reviewer concerns: cell-biology significance, scientific rigor, image-data integrity (especially for fluorescence microscopy, electron microscopy, or live-cell imaging papers), and reproducibility.
- JCB's single-round major-revision policy means your response must be comprehensive; there is no second chance at JCB if major revisions miss reviewer concerns.
- Read recent JCB papers in your subfield to calibrate the current editorial bar.
Readiness check
While you wait on Journal of Cell Biology, scan your next manuscript.
The scan takes about 2 to 3 minutes. Use the result to decide whether to revise before the decision comes back.
If JCB rejects: sister-journal cascade with reasoning
If your JCB paper is rejected after review, the natural cascade depends on what the reviewers and academic editor cited:
Molecular Biology of the Cell (MBoC) is the natural ASCB cascade for cell-biology mechanism papers where the JCB priority bar is not met but the rigor is high.
Journal of Cell Science (JCS) is the Company of Biologists cascade for cell-biology research.
Cell Reports is the external Cell Press cascade for broader life-sciences work. Cell Press uses Editorial Manager at Editorial Manager submission portal; editorial contact cellreports@cell.com.
Nature Cell Biology is the external Springer Nature cell-biology specialty cascade. The Nature Cell Biology Manuscript Tracking System at mts-ncb.nature.com handles submission; ncb@nature.com handles publisher-level inquiries.
Molecular Cell is the external Cell Press cascade for mechanism-depth molecular-biology cell-biology papers. Cell Press uses Editorial Manager at Editorial Manager submission portal; editorial contact molecular-cell@cell.com.
eLife is a cascade option for cell-biology work where the Reviewed Preprint model fits.
How JCB compares to nearby alternatives
Feature | JCB | Nature Cell Biology | Molecular Biology of the Cell | Journal of Cell Science |
|---|---|---|---|---|
Desk-rejection rate | About 70 percent (2024 JCB editor seminar; no official rate) | Not published | Not published | Not published |
Desk-decision speed | 3 to 4 day initial decision | 7 to 21 days | 7 to 14 days | 7 to 14 days |
Total review time (post-screen) | No published figure | 2 to 4 months | 4 to 8 weeks | 4 to 8 weeks |
Reviewer count | Not published (leading scientists active in the field) | 2 to 3 | 2 to 3 | 2 to 3 |
Peer-review model | In-house + academic collaborative, reviewers see each other's reports, single major revision | Single-blind, optional transparency | Single-blind | Company of Biologists single-blind |
Editorial bar | Top cell-biology priority + single-revision discipline | Top-tier Nature Portfolio cell-biology | ASCB cell-biology mechanism | Cell-biology research breadth |
Submit If
- Your abstract and first figure state a cell-biology principle that travels beyond one pathway, cell type, reagent, or organism.
- Your methods and Supporting Information make image acquisition, processing, quantification, controls, raw image access, and data availability easy to audit.
- Your revision plan can address all major reviewer concerns in one major revision, including new experiments, analysis, or a tightly reasoned rebuttal.
If your JCB paper is Under Review past 1 week, you have cleared the in-house + academic editor collaborative screen. Use the waiting window to prepare a comprehensive revision response template (remember: single round of major revision only at JCB).
JCB submission readiness check takes about 5 minutes.
Think Twice If
- Your abstract or first figure presents a pathway, cell type, or perturbation result without a broader cell-biology principle for JCB's readership.
- Your image methods table lacks acquisition settings, processing rules, quantification pipeline, raw image availability, controls, or replicate structure.
- Your response plan would need two sequential major-revision cycles because key reviewer concerns require new experiments, new controls, or a full reanalysis.
JCB says it re-reviews manuscripts only when necessary and that, in many cases, an academic editor makes the final decision on a resubmission without further expert review. JCB publishes no acceptance rate, so any overall figure (including the unofficial 15 to 20 percent estimate above) is directional only. The single-round revision policy raises the stakes for the first revision.
For a pre-upload diagnostic of cell-biology significance and image-data integrity, run a JCB pre-submission diagnostic before reviewer reports surface those concerns.
Last verified: JCB editorial policies at Rupress editorial team page and JCB submission guidelines.
The JCB reviewer experience
JCB's reviewer guidelines ask reviewers to comment on four things. The table below maps each to actionable preparation.
Reviewer focus area | What JCB asks reviewers to comment on | How to prepare for it |
|---|---|---|
Conceptual advance and broad interest | The level of conceptual advance and broad interest | Frame the introduction around the cell-biology principle the findings illuminate. |
Technical rigor | The technical rigor of the manuscript | Include detailed methods documentation. JCB requires IRB or ethics-committee approval for human-subjects and animal research and encourages reporting guidelines such as ARRIVE. |
Statistical analysis | The statistical analysis | Describe the statistical test, actual p-values, replicates, measure of center, and measure of variability, as JCB's guidelines ask. |
Presentation | The presentation of the manuscript | Keep figures and legends clear, and avoid inappropriate image manipulation: JCB screens the images in every accepted manuscript before publication. |
What we see in our pre-submission review work on Journal of Cell Biology manuscripts
This guide tells you what Journal of Cell Biology editors look for during the status window. Manusights has reviewed 50+ manuscripts targeting Journal of Cell Biology or adjacent cell-biology journals; full Manusights reviews include a 60-day money-back guarantee, and we do not train AI on customer manuscripts. Three recurring patterns separate strong JCB submissions from manuscripts that become difficult Under Review.
Manusights review data from this journal family shows a specific risk pattern: in practice, we see JCB editors and reviewers specifically look for image auditability and a broad cell-biology claim before they treat a visually strong figure set as JCB-ready.
Journal of Cell Biology manuscripts with narrow cell-biology framing in the abstract and first figure. The most common priority problem is not weak data. It is a manuscript that presents a pathway, cell type, perturbation, or imaging phenotype without making the general cell-biology principle visible. JCB editors can move quickly because they are asking whether the paper matters across the field, not whether the experiment is merely competent.
The fix usually requires rewriting the title, abstract, introduction close, and first figure narrative so the reader sees the cellular mechanism, spatial organization principle, trafficking logic, organelle behavior, or quantitative cell-biological insight before the subfield details take over.
Check whether your JCB cell-biology framing clears the priority bar ->
Journal of Cell Biology manuscripts with image-data and quantification gaps. Many JCB-targeted papers look visually persuasive but are thin in the methods table, image-processing description, raw image trail, or quantification pipeline. The weak spot can be acquisition settings, exposure changes, contrast handling, segmentation rules, batch effects, replicate structure, or missing raw data availability.
Because JCB's submission guidance puts responsibility on the corresponding author for data integrity and archiving, reviewers treat image auditability as part of the scientific claim. A strong package ties figure legends, methods, Supporting Information, raw data access, and controls into one readable evidence chain.
Check whether your JCB image-data package is reviewer-ready ->
Journal of Cell Biology manuscripts without single-revision discipline. JCB's single major-revision policy changes the meaning of Under Review. A manuscript can survive the first screen and still fail if the first response plan leaves major reviewer concerns unresolved. We see this most often when the authors treat reviewer comments as optional experiments rather than one coordinated revision package. Before the first decision arrives, build a response map against each figure, control, method, and data-availability issue so the revision can answer every material concern in one round.
Check whether your JCB single-revision response plan is complete ->
Methodology note
This page was created from Rockefeller University Press's public JCB editorial policies at Rupress editorial team page, JCB submission guidelines documentation (3 to 4 day initial decision, in-house professional + academic editor collaborative consultation model, single round of major revision policy), and Manusights pre-submission review experience with JCB-targeted manuscripts.
Source limitations: official guidance describes workflow mechanics, so the reviewer-risk guidance here is inferred from those sources plus Manusights manuscript-review patterns, not from private editorial records.
What to read next
For the cell-biology landscape beyond JCB, see Molecular Biology of the Cell (ASCB cell-biology mechanism), Journal of Cell Science (Company of Biologists cell-biology research), Cell Reports (Cell Press broader life-sciences), Nature Cell Biology (Springer Nature cell-biology specialty), Molecular Cell (Cell Press mechanism-depth), and eLife (Reviewed Preprint cell-biology).
The choice across these titles depends on whether the central contribution is top cell-biology priority (JCB), ASCB cell-biology mechanism (MBoC), Company of Biologists cell-biology research (JCS), Cell Press broader life-sciences (Cell Reports), Nature Portfolio cell-biology (Nature Cell Biology), Cell Press mechanism-depth (Molecular Cell), or Reviewed Preprint (eLife).
Reviewers at JCB typically draw from leading scientists active in the cell-biology subfield regardless of editorial board membership. Editors screen and triage manuscripts before any external reviewer sees them, and preparing a comprehensive revision response template that addresses every reviewer concern is essential given JCB's single-round major-revision policy.
For a pre-upload check of your manuscript against the JCB cell-biology-priority + image-integrity bar before submission, our JCB pre-submission diagnostic flags the framing and image-data weaknesses most likely to surface in reviewer reports.
Journal of Cell Biology Pre-Decision Checklist
- Confirm the abstract and first figure make the broad cell-biology principle visible before the specialized system details.
- Audit imaging methods for acquisition settings, processing rules, quantification pipeline, controls, replicate structure, raw image access, and data availability.
- Map each likely reviewer concern to a figure, method, control, or supplementary item so the first revision can be complete.
- Prepare a response template that assumes one major revision, not an open-ended sequence of revision rounds.
- Decide whether JCB, Molecular Biology of the Cell, Journal of Cell Science, Cell Reports, Nature Cell Biology, Molecular Cell, or eLife best fits the current manuscript.
Frequently asked questions
Your manuscript has cleared JCB the official source admin checks and is being evaluated. An initial decision whether to peer review the paper is typically reached within 3 to 4 days. At JCB, all editorial decisions on research manuscripts are made through collaborative consultation between in-house professional scientific editors and the academic editorial board. The final decision lies with the academic editors.
JCB reports that an initial decision is typically reached within 3 to 4 days. For papers sent for full review, the manuscript is refereed by leading scientists active in the relevant field regardless of their membership on the JCB editorial board. Following review, the journal will encourage resubmission if revisions seem feasible within 3 to 4 months.
Wait at least 4 weeks before inquiring. Contact the JCB editorial office through the online submission system, referencing your manuscript ID, or at cellbio@rockefeller.edu.
No. JCB publishes no median review time, so 4 weeks alone is not a warning sign. Reports may already be in editorial synthesis with the academic editor preparing the final decision.
Your paper passed the in-house professional editor + academic editor initial screen and the manuscript is refereed by leading scientists active in the relevant field regardless of their membership on the JCB editorial board. JCB maintains referee anonymity.
Yes, it can be. JCB publishes no median total time from submission to acceptance, and accepted-paper histories vary widely. JCB's policy is a single round of major revision.
Past 8 weeks is a reasonable moment for a polite inquiry. JCB publishes no review-time median, so this is general guidance rather than a journal rule, and a wait of a few weeks after the initial decision is not by itself a warning sign.
Sources
Free guide
Waiting is not the same as being ignored, and there is a way to tell.
Reviewers usually get ten days. When it has been months, an appeal and a complaint are different instruments with different addresses, and only one of them fits a delay. This is which to use, and the wording that gets an answer.
Final step
Done interpreting the status? Put the wait to work.
The Journal of Cell Biology decision will arrive on the journal's clock. What you control is what's next: scan your next manuscript free, or run this paper through the scan so the likely reviewer pushback is mapped before the revision request lands.
Free scan, no card needed.
Target journal Journal of Cell Biology
Private API processing. Your manuscript is not used to train models.
Re-read the status guidePut the guidance to work
Turn a decision into a clear next step.
Use the practical response workflow when a manuscript needs revision, or the process guide when you need to understand what the editorial status means.